Public & Investor Relations For
Biotech & Life Sciences
HLTH Communications helps biotech and life sciences companies explain complex science and connect with investors. We build communications programs that translate research and business milestones into compelling stories for the audiences that matter.
Amplify your story, ignite your success
At HLTH Communications, we specialize in transforming your unique story into powerful narratives that resonate and inspire. Our strategic approach leverages media relations, thought leadership, and innovative content strategies to amplify your brand’s presence and impact. By aligning your message with your audience’s values and interests, we help you ignite success, drive engagement, and achieve measurable business outcomes. Let us help you turn your vision into a compelling story that captivates and delivers results.
Our Services
Designed to meet the diverse needs of our clients
Thought Leadership
Developing and promoting expert insights positions you as a leader in your field, leveraging executive commentary, bylined articles, and speaking opportunities.
Investor Relations
Build and maintain strong investor relationships through transparent communication strategies that highlight financial performance and strategic vision.
Content Strategy & Design
Compelling content creation includes brand strategy, creative writing, immersive digital experiences, and visual storytelling that resonate with your audience.
Media Relations
Achieve targeted media coverage by aligning your messaging with trends and establishing credibility through strategic campaigns.
Social Media
Engage investor communities with data-driven social media strategies that amplify your message and enhance your online presence.
Events
Ensure high engagement and seamless delivery with flawlessly planned and executed events, from large-scale conferences to intimate exhibitions.
Areas of Focus
We've helped leading brands across industries achieve measurable growth and market leadership
Biotech
We provide strategic communications for biotech companies, ensuring their groundbreaking innovations receive the attention they deserve.
Neuropsychiatry
Our expertise in neuropsychiatric communications helps companies in this field effectively convey complex medical information.
Neuroscience
Our firm supports neuroscience companies by creating compelling narratives that explain their research and breakthroughs.
Mining
We deliver strategic communications for mining companies, helping them spotlight resource potential, navigate regulatory milestones, and attract investor interest at every stage—from exploration to production.
Mental Health
We specialize in promoting mental health initiatives and organizations, using strategic communications to raise awareness and reduce stigma.
Psychedelics
We help psychedelic research and therapy companies communicate their innovative approaches and scientific findings.
Longevity
Our communications expertise in the longevity sector focuses on promoting advancements in life extension and healthy aging.
The Results
The numbers speak for themselves
$40M+
Raised for Clients
3x
Dominance in industry conversations within 6 months
65%
Average client year-over-year growth
Download Our e-Book
Discover the Secrets to Successful Communication
Client Case Studies
Learn How We Did It
Our Clients Have Been Featured In
Founders Led
Meet Our Team
Natalie Dolphin
🇨🇦 Toronto, Canada
Natalie Dolphin has over 15 years of experience in marketing, business development, and capital markets. She has a proven track record in raising capital, having secured $40M+ USD for clients, and excels in driving business growth and securing investment opportunites.
Mentions in the Press
Celebrating Our Clients' success
Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate
Enveric Biosciences Inc. (NASDAQ:ENVB) reported favorable outcomes from IND-enabling laboratory studies evaluating its primary drug candidate, EB-003. “These results represent an important milestone in the development of EB-003, provide additional support for its preclinical development profile, and support its continued advancement toward a planned first-in-human clinical trial,” said Joseph Tucker, Director and CEO of Enveric.
Read Now
Can An Ibogaine Analog Preserve The Therapeutic Potential Without The Trip Or Cardiac Risk?
Ibogaine’s anecdotal and clinical signals on cravings, withdrawal, and even PTSD are growing, but the biggest obstacle is that ibogaine itself carries serious cardiac risk (QT prolongation, arrhythmias) and can produce an intense psychedelic experience lasting 10 hours or more, which would necessitate prolonged medical supervision in a clinical setting.
Read Now
What The FDA’s Latest Move On Psychedelics Means For Non-Hallucinogenic Drug Sponsors
The Psychedelic Drugs resource page added to the FDA website might be yet another indicator that the regulator is increasingly interested in the field’s potential. In publishing this resource page, which sits alongside one dedicated to drug repurposing, the agency has coalesced July’s finalized guidance for the field and April’s executive order as well as […]
Read Now
Demi Moore, 63, Is Aging in Reverse as Surgeon Weighs in on ‘Natural’ Procedure That Could Be Behind Her Timeless Look: See Before-and-After Photos
Radar previously reported that Moore may have achieved “smooth contour of the upper face” with the help of fat grafting or maybe even a brow lift. “She likely had a brow or forehead lift and fat grafting of the temple area to achieve a smooth contour of the upper face,” plastic surgeon Dr. Tia Liu […]
Read Now
The Next Evolution of Psychedelic Medicine May Not Be Psychedelic at All
As clinical research advances beyond first-generation compounds, scientists are rethinking what psychedelic-inspired therapies could look like and how they may reshape the future of mental healthcare. For decades, psychedelic compounds occupied the fringes of medical research. Today, they’re at the center of one of the most active areas of neuroscience. From psilocybin and LSD to […]
Read Now
New antidepressants: Tackling treatment resistant depression
Enveric’s lead candidate, EB-003, is a novel neuroplastogen that engages both the 5-HT2A and 5-HT1B receptors, a dual mechanism that may define a new class of neuropsychiatric treatments. This pharmacological profile is designed to promote adaptive rewiring of brain circuits while stabilizing emotional and behavioral regulation, potentially enabling durable recovery in patients with post-traumatic stress disorder (PTSD), treatment-resistant […]
Read Now
The Business of Hlth Podcast
Listen to the latest episode of our podcast
The Business of HLTH podcast, a HLTH Communications Production, provides an in-depth look at the evolving health sector. We interview investors and innovators, exploring the latest in health tech, longevity and biotech investments, uncovering where capital is moving. Join us for insights into the future of health.
How we will work with you
Our Process
1 Research
Our initial focus will be on examining your past actions to determine what has been effective and what hasn’t. We’ll also delve into understanding your target audience, collecting essential messages and materials, and clarifying your objectives. Additionally, we’ll analyze your competitors’ marketing strategies to identify successful approaches.
2 Implementation
Following the research phase, we’ll develop and align a Media Relations program with your broader marketing strategy. This will involve setting up your press office and brainstorming pitch ideas.
3 Pitch Pitch Pitch
Through meticulous planning, organization, and interaction with journalists, we aim to secure high-quality coverage for you. This will contribute significantly to building a positive and robust media presence, which will be highly valued by your customers and search engines like Google.
4 Evaluation
You’ll have real-time access to information about our pitch efforts, ongoing conversations with targeted journalists, and all metrics related to secured coverage.
Testimonials
Hear from Happy Customers
Take Your First Steps
Are you ready to elevate your brand?
Explore how we can help you achieve your goals and drive tangible business results.